Zaitsu Masayoshi, Toyokawa Satoshi, Tonooka Akiko, Nakamura Fumiaki, Takeuchi Takumi, Homma Yukio, Kobayashi Yasuki
Department of Public Health, The University of Tokyo, Tokyo, Japan; Department of Urology, Kanto Rosai Hospital, Kawasaki, Japan; Department of Urology, The University of Tokyo, Tokyo, Japan.
Cancer Med. 2015 Mar;4(3):363-70. doi: 10.1002/cam4.379. Epub 2014 Dec 23.
Sex differences in bladder cancer pathology and epidemiology have been the focus of recent research. We investigated the epidemiological characteristics and compared bladder cancer pathology and survival between men and women in Japan. A total of 13,184 patients with primary bladder cancer diagnosed from 1954 to 2010 were identified in a large-scale cancer registry database in Kanagawa Prefecture. Using this database, we compared the odds ratios (ORs) for nonurothelial carcinoma (non-UC) using a multiple logistic regression model adjusted for age and diagnosis periods. We also compared hazard ratios (HRs) for overall death and cancer-specific death using a Cox proportional hazards model adjusted for non-UC, age, and diagnosis period. The proportion of non-UC was significantly higher in female compared with male patients (OR = 2.14, 95% confidence interval [CI]: 1.81-2.52). Furthermore, survival was significantly poorer in female patients than in male patients after adjusting for UC or non-UC (HR for overall death = 1.15, 95% CI: 1.06-1.23; HR for cancer-specific death = 1.39, 95% CI: 1.28-1.52). Sex differences exist in the epidemiological characteristics of bladder cancer in Japan, with female patients having less favorable pathology and poorer survival compared with male patients.
膀胱癌病理与流行病学中的性别差异一直是近期研究的重点。我们调查了日本男性和女性膀胱癌的流行病学特征,并比较了两者的膀胱癌病理及生存率。在神奈川县的一个大规模癌症登记数据库中,共识别出1954年至2010年期间确诊的13184例原发性膀胱癌患者。利用该数据库,我们使用经年龄和诊断时期调整的多重逻辑回归模型,比较了非尿路上皮癌(non-UC)的比值比(OR)。我们还使用经non-UC、年龄和诊断时期调整的Cox比例风险模型,比较了总体死亡和癌症特异性死亡的风险比(HR)。女性患者中non-UC的比例显著高于男性患者(OR = 2.14,95%置信区间[CI]:1.81 - 2.52)。此外,在调整UC或non-UC后,女性患者的生存率显著低于男性患者(总体死亡的HR = 1.15,95% CI:1.06 - 1.23;癌症特异性死亡的HR = 1.39,95% CI:1.28 - 1.52)。日本膀胱癌的流行病学特征存在性别差异,女性患者的病理情况较差,生存率低于男性患者。